Suggestive evidence of erythropoietin level abnormality in patients with sporadic and familial cases of the restless leqs syndrome

Neuroendocrinology Letters

Volumn 28, Issue 5, 2007, Pages 643-646

  Kemlink, David ^a   Šonka, Karel ^a   Pretl, Martin ^a   Benáková, Hana ^a   Zima, Tomáš ^a   Nevšímalová, Soňa ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Biochemical parameters; Erythropoietin; Hematological parameters; Restless legs syndrome

Indexed keywords

BIOCHEMICAL MARKER; CREATININE; CYANOCOBALAMIN; ERYTHROPOIETIN; FERRITIN; FOLIC ACID DERIVATIVE; HEMOGLOBIN; IRON; TRANSFERRIN; TRANSFERRIN RECEPTOR; UREA;

ADULT; ARTICLE; BLOOD CELL COUNT; BLOOD EXAMINATION; ENDEMIC DISEASE; ERYTHROCYTE; ERYTHROCYTE VOLUME; FAMILIAL DISEASE; FAMILY HISTORY; FEMALE; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRON BINDING CAPACITY; IRON BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PHENOTYPE; RESTLESS LEGS SYNDROME; RETROSPECTIVE STUDY; VITAMIN BLOOD LEVEL;

EID: 38049018987     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisir J. Restless Legs Syndrome Diagnosis and Epidemiology workshop at the National Institutes of Health; International Restless Legs Syndrome Study Group, Restless legs syndrome, diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003; 4: 101-119.
2. Barriére G, Cazalets JR, Bioulac B, Tison F, Ghorayeb I. The restless legs syndrome. Progress Neurobiol 2005; 77: 139-165.
3. Benz RI, Pressman MR, Hovick ET, Peterson DD. A preliminary study of the effects of correction of anemia with recombinant human erythropoietin therapy on sleep, sleep disorders, and daytime sleepiness in hemodialysis patients (The SLEEPO Study). Am J Kidney Dis 1999; 34: 1089-1095.
4. Berger K, Luedemann J, Trenkwalder C, John, U., Kessler, C. Sex and the risk of restless legs syndrome in the general population. Arch Intern Med 2004; 164: 196-202.
5. Bernaudin M, Bellail A, Marti HH, Yvon A, Vivien D, Duchatelle I, Mackenzie ET, Petit E. Neurons and astrocytes express EPO mRNA: oxygen-sensing mechanisms that involve the redox-state of the brain. Glia 2000; 30: 271-278.
6. Cahan C, Decker MJ, Arnold JL, Washington LH, Veldhuis JD, Goldwasser E, Strohl KP. Diurnal variations in serum erythropoietin levels in healthy subjects and sleep apnea patients. J Appl Physiol 1992; 72: 2112-2117.
7. Chin K, Yu X, Beleslin-Cokic B, Liu C, Shen K, Mohrenweiser HW, Noguchi CT. Production and processing of erythropoietin receptor transcripts in brain. Mol Brain Res 2000; 81: 29-42.
8. Diaz Z, Assaraf MI, Miller WH Jr, Schipper HM. Astroglial cytoprotection by erythropoietin pre-conditioning: implications for ischemic and degenerative CNS disorders. J Neurochem. 2005; 93: 392-402.
9. Digicaylioglu M, Bichet HH, Marti RH, Wenger LA, Rivas C, Bauer M, Gassmann M. Localization of specific erythropoietin binding sites in defined areas of the mouse brain. Proc Natl Acad Sci U.S.A. 1995; 92: 3717-3720.
10. Garcia-Garcia F, Krueger JM. Intracerebroventricular injection of erythropoietin enhances sleep in the rat. Brain Res Bull 2003; 61: 541-546.
11. Högl B, Kiechl S, Willeit J, Saletu M, Frauscher B, Seppi K, Muller J, Rungger G, Gasperi A, Wenning G, Poewe W. Restless legs syndrome: a community-based study of prevalence, severity, and risk factors. Neurology 2005; 64: 1920-4.
12. Kemlink D, Šonka K, Nevšímalová S, Pretl M, Benáková M, Zima T, Pantelakis L, Serranová T. Rodinné a sporadické formy syndromu neklidných nohou. Ces a Slov Neurol Neurochir 2003; 6: 387-91.
13. Koshimura K, Murakami Y, Sohmiya M, Tanaka J, Kato Y. Effects of erythropoietin on neuronal activity. J Neurochem 1999; 72: 2565-2572.
14. Krantz SB. Erythropoietin, Blood 1991; 77: 419-434.
15. Li Y, Lu Z, Keogh CL, Yu SP, Wei L. Erythropoietin-induced neurovascular protection, angiogenesis, and cerebral blood flow restoration after focal ischemia in mice. J Cereb Blood Flow Metab. 2007; 27: 1043-1054.
16. Winkelmann J, Wetter TC, Collado-Seidel V. Clinical characteristics and frequency of the hereditary restless legs syndrome in a population of 300 patients. Sleep 2000; 23: 597-602.
17. Wolcott DL, Marsh JT, La Rue A, Carr C, Nissenson AR. Recombinant human erythropoietin treatment may improve duality of life and cognitive function in chronic hemodialysis patients. Am J Kidney Dis 1989; 14: 478-485.